| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |